C.C.P. Verstappen

2.2k total citations
17 papers, 890 citations indexed

About

C.C.P. Verstappen is a scholar working on Oncology, Neurology and Molecular Biology. According to data from OpenAlex, C.C.P. Verstappen has authored 17 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Neurology and 5 papers in Molecular Biology. Recurrent topics in C.C.P. Verstappen's work include Cancer Treatment and Pharmacology (8 papers), Mitochondrial Function and Pathology (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). C.C.P. Verstappen is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Mitochondrial Function and Pathology (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). C.C.P. Verstappen collaborates with scholars based in Netherlands, Germany and United States. C.C.P. Verstappen's co-authors include J.J. Heimans, Tjeerd J. Postma, Klaas Hoekman, Bastiaan R. Bloem, T.J. Postma, Susanne Koeppen, M. E. Scheulen, Dirk Strumberg, Peter C. Huijgens and Bart P.C. van de Warrenburg and has published in prestigious journals such as Neurology, Drugs and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

C.C.P. Verstappen

17 papers receiving 859 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
C.C.P. Verstappen 333 214 213 207 144 17 890
T.J. Postma 538 1.6× 180 0.8× 460 2.2× 550 2.7× 87 0.6× 15 1.2k
R. Plasmati 507 1.5× 451 2.1× 74 0.3× 124 0.6× 327 2.3× 42 1.5k
A. Hovestadt 140 0.4× 317 1.5× 209 1.0× 161 0.8× 42 0.3× 19 746
Timothée Lenglet 231 0.7× 870 4.1× 159 0.7× 500 2.4× 349 2.4× 58 1.6k
Tae Hyung Han 375 1.1× 49 0.2× 48 0.2× 82 0.4× 125 0.9× 47 872
Satoru Ishibashi 108 0.3× 187 0.9× 160 0.8× 129 0.6× 381 2.6× 66 1.3k
Francesca Pastorelli 412 1.2× 183 0.9× 64 0.3× 93 0.4× 282 2.0× 28 980
Sindhu Ramchandren 93 0.3× 260 1.2× 36 0.2× 88 0.4× 98 0.7× 37 590
John M. Slopis 186 0.6× 1.1k 5.2× 345 1.6× 178 0.9× 296 2.1× 69 1.8k
S. Jann 184 0.6× 722 3.4× 51 0.2× 70 0.3× 125 0.9× 36 1.3k

Countries citing papers authored by C.C.P. Verstappen

Since Specialization
Citations

This map shows the geographic impact of C.C.P. Verstappen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.C.P. Verstappen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.C.P. Verstappen more than expected).

Fields of papers citing papers by C.C.P. Verstappen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.C.P. Verstappen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.C.P. Verstappen. The network helps show where C.C.P. Verstappen may publish in the future.

Co-authorship network of co-authors of C.C.P. Verstappen

This figure shows the co-authorship network connecting the top 25 collaborators of C.C.P. Verstappen. A scholar is included among the top collaborators of C.C.P. Verstappen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.C.P. Verstappen. C.C.P. Verstappen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Schinagl, Dominic A.X., et al.. (2016). Botulinum toxin-A injections vs radiotherapy for drooling in ALS. Acta Neurologica Scandinavica. 134(3). 224–231. 26 indexed citations
2.
Keus, S.H.J., et al.. (2013). The effectiveness of allied health care in patients with ataxia: a systematic review. Journal of Neurology. 261(2). 251–258. 54 indexed citations
3.
Keus, S.H.J., et al.. (2013). Physiotherapy in Degenerative Cerebellar Ataxias: Utilisation, Patient Satisfaction, and Professional Expertise. The Cerebellum. 12(6). 841–847. 22 indexed citations
4.
Schmitz‐Hübsch, Tanja, C.C.P. Verstappen, Bastiaan R. Bloem, et al.. (2012). Prospective Analysis of Falls in Dominant Ataxias. European Neurology. 69(1). 53–57. 36 indexed citations
5.
Rooij, Frank G. van, et al.. (2009). A throbbing pain in the head: trastuzumab-induced migraine.. PubMed. 29(10). 4223–5. 2 indexed citations
6.
Bakker, M., C.C.P. Verstappen, Bastiaan R. Bloem, & Ivan Toni. (2007). Recent advances in functional neuroimaging of gait. Journal of Neural Transmission. 114(10). 1323–1331. 47 indexed citations
7.
Snijders, Anke H., C.C.P. Verstappen, Marten Munneke, & Bastiaan R. Bloem. (2007). Assessing the interplay between cognition and gait in the clinical setting. Journal of Neural Transmission. 114(10). 1315–1321. 33 indexed citations
8.
Verstappen, C.C.P., Bastiaan R. Bloem, Charlotte A. Haaxma, Wim J.G. Oyen, & M.W.I.M. Horstink. (2006). Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson’s disease: an [123I]IBZM and [123I]FP-CIT SPECT study. European Journal of Nuclear Medicine and Molecular Imaging. 34(4). 502–507. 31 indexed citations
9.
Verstappen, C.C.P., Tjemme Beems, Corrie E. Erasmus, & Erik J. van Lindert. (2005). Dumbbell trigeminal schwannoma in a child: complete removal by a one-stage pterional surgical approach. Child s Nervous System. 21(11). 1008–1011. 14 indexed citations
10.
Verstappen, C.C.P., Susanne Koeppen, J.J. Heimans, et al.. (2005). Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening. Neurology. 64(6). 1076–1077. 136 indexed citations
11.
Koeppen, Susanne, C.C.P. Verstappen, M. E. Scheulen, et al.. (2004). Lack of neuroprotection by an ACTH (4?9) analogue. A randomized trial in patients treated with vincristine for Hodgkin?s or non-Hodgkin?s lymphoma. Journal of Cancer Research and Clinical Oncology. 130(3). 153–160. 26 indexed citations
12.
Verstappen, C.C.P., Tjeerd J. Postma, Albert A. Geldof, & J.J. Heimans. (2004). Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation.. PubMed. 24(4). 2337–41. 23 indexed citations
13.
Verstappen, C.C.P., et al.. (2003). Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancer. Journal of Neuro-Oncology. 63(2). 201–205. 20 indexed citations
14.
Verstappen, C.C.P., J.J. Heimans, Klaas Hoekman, & Tjeerd J. Postma. (2003). Neurotoxic Complications of Chemotherapy in Patients with Cancer. Drugs. 63(15). 1549–1563. 324 indexed citations
15.
Laarhoven, Hanneke W.M. van, C.C.P. Verstappen, L.V.A.M. Beex, A.C. Kappelle, & Cornelis J. A. Punt. (2003). 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug.. PubMed. 23(1B). 647–8. 4 indexed citations
16.
Postma, T.J., Martin Klein, C.C.P. Verstappen, et al.. (2002). Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology. 59(1). 121–123. 74 indexed citations
17.
Verstappen, C.C.P., A.A. Geldof, Tjeerd J. Postma, & J.J. Heimans. (1999). In Vitro Protection from Cisplatin-induced Neurotoxicity by Amifostine and its Metabolite WR1065. Journal of Neuro-Oncology. 44(1). 1–5. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026